In both the studies, SNHG12 expression was positively correlated with tumor size, stage, lymph node metastasis, and distant metastasis; whereas, no correlation was found with other clinicopathological characteristics such as patient age and gender. The gene discussed is SNHG12; the disease is metastatic malignant neoplasm in the lymph nodes.